Inspire Medical Systems Total Assets 2017-2024 | INSP

Inspire Medical Systems total assets from 2017 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Inspire Medical Systems total assets for the quarter ending September 30, 2024 were $0.796B, a 24.5% increase year-over-year.
  • Inspire Medical Systems total assets for 2023 were $0.677B, a 19.82% increase from 2022.
  • Inspire Medical Systems total assets for 2022 were $0.565B, a 91.43% increase from 2021.
  • Inspire Medical Systems total assets for 2021 were $0.295B, a 4.94% increase from 2020.
Inspire Medical Systems Annual Total Assets
(Millions of US $)
2023 $677
2022 $565
2021 $295
2020 $281
2019 $181
2018 $200
2017 $25
2016 $0
Inspire Medical Systems Quarterly Total Assets
(Millions of US $)
2024-09-30 $796
2024-06-30 $728
2024-03-31 $686
2023-12-31 $677
2023-09-30 $639
2023-06-30 $618
2023-03-31 $572
2022-12-31 $565
2022-09-30 $528
2022-06-30 $292
2022-03-31 $290
2021-12-31 $295
2021-09-30 $279
2021-06-30 $272
2021-03-31 $273
2020-12-31 $281
2020-09-30 $272
2020-06-30 $271
2020-03-31 $166
2019-12-31 $181
2019-09-30 $183
2019-06-30 $186
2019-03-31 $190
2018-12-31 $200
2018-09-30 $131
2018-06-30 $134
2018-03-31 $28
2017-12-31 $25
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.276B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00